PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
+7.9%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$151M
AUM Growth
+$151M
(+2.7%)
Cap. Flow
-$7.43M
Cap. Flow
% of AUM
-4.94%
Top 10 Holdings %
Top 10 Hldgs %
43.1%
Holding
92
New
16
Increased
11
Reduced
15
Closed
20
Top Buys
| 1 |
Baxter International
BAX
|
$7.63M |
| 2 |
Bruker
BRKR
|
$6.43M |
| 3 |
SPNC
Spectranetics Corp
SPNC
|
$4.22M |
| 4 |
LivaNova
LIVN
|
$4.01M |
| 5 |
Cooper Companies
COO
|
$3.36M |
Top Sells
| 1 |
Stryker
SYK
|
$4.88M |
| 2 |
Bausch Health
BHC
|
$4.13M |
| 3 |
CYBX
CYBERONICS INC
CYBX
|
$3.65M |
| 4 |
Abbott
ABT
|
$3.22M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
$2.95M |
Sector Composition
| 1 | Healthcare | 88.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cigna
CI
$80.3B
| $8.41M | 3.55% | 57,500 -3,500 | -6% | -$512K |
|
|
2
Baxter International
BAX
$12.7B
| $7.63M | 3.22% | +200,000 | New | +$7.63M |
|
3
Teleflex
TFX
$5.59B
| $7.23M | 3.05% | 55,000 -2,500 | -4% | -$329K |
|
4
Insulet
PODD
$23.9B
| $7.17M | 3.02% | 189,501 +8,901 | +5% | +$337K |
|
|
5
Bruker
BRKR
$5.16B
| $6.43M | 2.71% | +265,000 | New | +$6.43M |
|
6
Boston Scientific
BSX
$156B
| $6.18M | 2.61% | 335,000 -80,000 | -19% | -$1.48M |
|
7
Pfizer
PFE
$141B
| $5.89M | 2.49% | 182,500 -12,375 | -6% | -$399K |
|
8
AbbVie
ABBV
$372B
| $5.63M | 2.38% | 95,000 +21,000 | +28% | +$1.24M |
|
9
Owens & Minor
OMI
$378M
| $5.25M | 2.22% | 145,900 +75,900 | +108% | +$2.73M |
|
10
Universal Health Services
UHS
$11.6B
| $5.08M | 2.14% | 42,500 -22,300 | -34% | -$2.66M |
|
|
NXTM
11
DELISTED
NxStage Medical Inc.
NXTM
| $4.6M | 1.94% | 210,000 -100,000 | -32% | -$2.19M |
|
|
WMGI
12
DELISTED
Wright Medical Group Inc
WMGI
| $4.5M | 1.9% | 186,000 -24,101 | -11% | -$583K |
|
|
NUVA
13
DELISTED
NuVasive, Inc.
NUVA
| $4.33M | 1.83% | 80,000 +7,220 | +10% | +$391K |
|
|
SPNC
14
DELISTED
Spectranetics Corp
SPNC
| $4.22M | 1.78% | +280,266 | New | +$4.22M |
|
|
15
LivaNova
LIVN
$3.08B
| $4.01M | 1.69% | +67,500 | New | +$4.01M |
|
16
Bristol-Myers Squibb
BMY
$96B
| $3.98M | 1.68% | 57,800 +4,050 | +8% | +$279K |
|
|
AGN
17
DELISTED
Allergan plc
AGN
| $3.94M | 1.66% | 12,600 +5,600 | +80% | +$1.75M |
|
|
18
Cooper Companies
COO
$13.4B
| $3.36M | 1.42% | +25,000 | New | +$3.36M |
|
|
CYNA
19
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $3.01M | 1.27% | 194,461 | – | – |
|
20
Eli Lilly
LLY
$657B
| $2.91M | 1.23% | 34,500 -9,750 | -22% | -$822K |
|
21
Accuray
ARAY
$157M
| $2.9M | 1.23% | 430,000 -283,700 | -40% | -$1.92M |
|
22
Agilent Technologies
A
$35.7B
| $2.72M | 1.15% | +65,000 | New | +$2.72M |
|
|
ELGX
23
DELISTED
Endologix Inc
ELGX
| $2.67M | 1.13% | 270,000 +64,900 | +32% | +$643K |
|
|
AFFX
24
DELISTED
AFFYMETRIX INC
AFFX
| $2.62M | 1.1% | 259,309 -20,691 | -7% | -$209K |
|
25
Zimmer Biomet
ZBH
$21B
| $2.57M | 1.08% | +25,000 | New | +$2.57M |
|